Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide by Rocha N. et al.
Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show
elevated baseline levels of secreted cytokines but resist stimulation with
β-amyloid peptide
Natália Pessoa Rocha a, Antônio Lúcio Teixeira b, Fernanda Matos Coelho a, Paulo Caramelli b,
Henrique Cerqueira Guimarães b, Izabela Guimarães Barbosa a, Tarcilia Aparecida da Silva a,
Marat Alexandrovich Mukhamedyarov c, Andrey Lvovich Zeﬁrov c, Albert Anatolyevich Rizvanov d,e,f,g,
Andrey Pavlovich Kiyasov g,h, Luciene B. Vieira a, Zoltán Janka i, András Palotás j,⁎, Helton José Reis a
a Laboratório de Neurofarmacologia, Departamento de Farmacologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (ICB-UFMG), Avenida Antônio Carlos 6627,
31270-901 Campus Pampulha, Belo Horizonte, Minas Gerais, Brazil
b Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Avenida Alfredo Balena 190, 30130-100 Belo Horizonte, Minas Gerais, Brazil
c Department of Physiology, Kazan State Medical University, ul. Butlerova 49, R-420012 Kazan, Russia
d Department of Genetics, Faculty of Biology and Soil Sciences, Kazan Federal University, ul. Kremlevskaya 18, R-420008 Kazan, Russia
e Core Research Laboratory, Kazan State Medical University, ul. Butlerova 49, R-420012 Kazan, Russia
f Department of Genetics and Bioengineering, College of Engineering and Architecture, Yeditepe University, 26 Ağustos Campus, Kayisdagi cad., Kayisdagi, 34755 Istanbul, Turkey
g Republic Clinical Hospital, ul. Orenburg tract 138, R-420064 Kazan, Russia
h Department of Anatomy, Kazan State Medical University, ul. Butlerova 49, R-420012 Kazan, Russia
i Department of Psychiatry, Albert Szent-Györgyi Clinical Center, Faculty of Medicine, University of Szeged, H-6721 Szeged, Semmelweis u. 6, Hungary
j Asklepios-Med (private medical practice and research center), H-6722 Szeged, Kossuth Lajos sgt. 23, Hungary
a b s t r a c ta r t i c l e i n f o
Article history:
Received 25 November 2010
Revised 11 September 2011
Accepted 19 September 2011







Peripheral blood mono-nuclear cell (PBMC)
Objectives: Among several other factors, the neuro-toxic β-amyloid peptide (βAP)-induced inﬂammatory
mechanisms have also been implicated in the pathogenesis of Alzheimer's dementia (AD). Cytokines
have recently emerged as prime candidates underlying this immune reaction. The purpose of this study
was to evaluate the inﬂammatory response of peripheral blood mono-nuclear cells (PBMC) in AD.
Design: Cross-sectional (observational) study.
Setting: Behavioral and cognitive neurology clinic of the Universidade Federal de Minas Gerais in Belo
Horizonte, Brazil.
Participants: AD patients (n=19), healthy elderly (n=19) and young (n=14) individuals.
Measurements: Cytokine levels were assessed by enzyme-linked immuno-sorbent assay (ELISA) after exposing
cells to a broad range of βAP concentrations (10−4–10−10 M) as a stimulus. AD samples were weighed against
leukocytes harvested from non-demented young and elderly subjects.
Results: Cytokine production of PBMCs in the youth was characterized by low baseline levels when compared to
cells from the older generation. In the aging population, AD cells were distinguished from the healthy elderly
sub-group by an even higher basal cytokine secretion. The low resting concentration in young individuals
was markedly increased after treatment with βAP, however cells from the elderly, irrespective of their disease
status, showed unchanged cytokine release following βAP administration. Non-speciﬁc activation of PBMCs
with anti-CD3/CD28 antibodies resulted in elevated interleukin (IL)-1β concentrations in AD.
Conclusions: These results demonstrate a general over-production of cytokines and resistance to βAP in the old
comparison group, with a more pronounced disruption/boosted pattern in AD. Our ﬁndings are in line with the
hypothesis of “inﬂammaging”, i.e. an enhanced inﬂammatory proﬁle with normal aging and a further perturbed
environment in AD. The observed cytokine proﬁles may serve as diagnostic biomarkers in dementia.
© 2011 Elsevier Inc. All rights reserved.
Introduction
Alzheimer's disease (AD) is a neuro-degenerative disorder charac-
terized by progressive loss of cognitive functions, especially memory
(Alzheimer's Association, 2009). The main histo-pathological picture
consists of neuronal loss in selected brain regions, as well as deposition
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